Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Rationalizing the approach to children with fever in neutropenia
Roland A. Ammann
,
Wim J.E. Tissing
, Bob Phillips
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rationalizing the approach to children with fever in neutropenia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fever in Neutropenia
100%
Low Risk
33%
Clinical Practice
33%
Pediatric Fever
33%
Children with Cancer
16%
Pediatric
16%
Chemotherapy
16%
Meta-analysis
16%
Standard of Care
16%
Clinical Characteristics
16%
Polymerase Chain Reaction
16%
Risk Stratification
16%
First Day
16%
Systematic Meta-analysis
16%
Polymerase Chain Reaction Assay
16%
Young Cancer Patients
16%
Risk Prediction Model
16%
Intravenous Antibiotics
16%
Life-threatening Complications
16%
Clinical Research
16%
Reaction-based
16%
Evidence-based Guidelines
16%
Everyday Practices
16%
New Standards
16%
New Diagnostics
16%
Oral Antibiotics
16%
Diagnostic Strategy
16%
Cross-sectional Imaging
16%
Laboratory Features
16%
Outpatient Management
16%
Medicine and Dentistry
Neutropenia
100%
Pediatrics
50%
Diagnosis
33%
Polymerase Chain Reaction
33%
Malignant Neoplasm
16%
Risk Stratification
16%
Systematic Review
16%
Health Care Cost
16%
Meta-Analysis
16%
Antibiotics
16%
Outpatient
16%
Infancy
16%
Cross-Sectional Imaging
16%
Chemotherapy
16%
Adolescence
16%
Nursing and Health Professions
Neutropenia
100%
Clinical Practice
33%
Diagnosis
33%
Polymerase Chain Reaction
33%
Malignant Neoplasm
16%
Systematic Review
16%
Meta Analysis
16%
Adolescent
16%
Practice Guideline
16%
Health Care Quality
16%
Imaging
16%
Outpatient
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neutropenia
100%
Malignant Neoplasm
16%
Chemotherapy
16%
Antibiotics
16%